shire map
Select a
Location

Shire Global

Newsroom

INTUNIV® (guanfacine hydrochloride prolonged release), a non-stimulant for the treatment of ADHD, receives approval in Japan

This press release is not intended for distribution in the U.S.

By clicking on the “Accept” button below, you hereby acknowledge that you are not based in the U.S. and do not intend to distribute this press release in the U.S.

By clicking on the “Decline” button below, you will not be able to proceed to the press release.

Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE